Epidemiological Landscape of Cervical Cancer in Latin America

Active, not recruiting

• Conditions: Uterine Cervical Neoplasms

• Registration Number: NCT04947605
• Lead Sponsor: Latin American Cooperative Oncology Group

Brief Summary

A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-06-24
• Study First Submitted QC: 2021-06-24
• Study First Posted: 2021-07-01
• Study Start: 2021-11-04
• Primary Completion: 2023-03-13
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-03
• Last Update Posted: 2024-07-05
• Study Completion: 2028-03

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: Female
• Target Recruitment: 524

Inclusion Criteria

• Women > 18 years.
• Histologically proven cervical carcinoma
• Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment.
• Any histology of cervical cancer at time of diagnosis.
• FIGO stage IB2-IVA
• Have available and adequate medical records for data collection
• Accept to participate in the project and sign the informed consent (if applicable)

Exclusion Criteria

• FIGO stage I and IB1
• Non-invasive cervical cancer
• Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Summarize the histologic subtype	January of 2028	Summarize the histologic subtype, assessed by the anatomopathological assay of the tumor sample and the stage at diagnosis, assessed by FIGO stage (International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri - 2018), using gynecological exam. Image studies and TNM stage (AJCC 8th edition) will also be used to assess stage at diagnosis when available.

Trial Locations

Locations (1)

A Real e Benemérita Associação Portuguesa de Beneficência; 🇧🇷 São Paulo, Brazil